Agfa buys stake in RIS firm

Article

Agfa Healthcare has expanded its RIS portfolio with the purchase of a minority stake in Med2Rad, an Italian medical software company. Med2Rad developed the Elefante RIS, currently installed in more than 75 Italian hospitals. The Belgian company has for

Agfa Healthcare has expanded its RIS portfolio with the purchase of a minority stake in Med2Rad, an Italian medical software company. Med2Rad developed the Elefante RIS, currently installed in more than 75 Italian hospitals. The Belgian company has for several years been the exclusive marketer and vendor for Elefante in the Italian market, as part of an integrated RIS/PACS and as a stand-alone RIS. Agfa made the investment to allow greater integration between its Impax and Med2Rad's Elefante, leading eventually to a common IT platform, according to the firm.

Recent Videos
Emerging Insights on the Use of FES PET for Women with Lobular Breast Cancer
Can Generative AI Reinvent Radiology Reporting?: An Interview with Samir Abboud, MD
Mammography Study Reveals Over Sixfold Higher Risk of Advanced Cancer Presentation with Symptom-Detected Cancers
Combining Advances in Computed Tomography Angiography with AI to Enhance Preventive Care
Study: MRI-Based AI Enhances Detection of Seminal Vesicle Invasion in Prostate Cancer
What New Research Reveals About the Impact of AI and DBT Screening: An Interview with Manisha Bahl, MD
Can AI Assessment of Longitudinal MRI Scans Improve Prediction for Pediatric Glioma Recurrence?
A Closer Look at MRI-Guided Adaptive Radiotherapy for Monitoring and Treating Glioblastomas
Incorporating CT Colonography into Radiology Practice
What New Research Reveals About Computed Tomography and Radiation-Induced Cancer Risk
Related Content
© 2025 MJH Life Sciences

All rights reserved.